Filing Details
- Accession Number:
- 0001209191-21-050055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-05 19:34:09
- Reporting Period:
- 2021-08-03
- Accepted Time:
- 2021-08-05 19:34:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1662579 | C4 Therapeutics Inc. | CCCC | Biological Products, (No Disgnostic Substances) (2836) | 475617627 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1824863 | Stewart Fisher | C/O C4 Therapeutics, Inc. 490 Arsenal Way #200 Watertown MA 02472 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-08-03 | 17,057 | $45.01 | 22,744 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.